Coronavirus Update With Michael T. Osterholm, PhD, MPH - September 23, 2020
Coronavirus Update With Michael T. Osterholm, PhD, MPH - September 23, 2020
Mike Osterholm returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. He is Director of the Center for Infectious Disease Research and Policy (CIDRAP) at University of Minnesota and a veteran of pandemic planning. Recorded September 23, 2020.Watch his June 24 appearance at https://youtu.be/64piemCeDGE
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
Topics discussed in this interview:
0:00 Introduction
0:47 What we've learned
1:50 Outlook for the Fall
2:55 Schools and Colleges
5:11 Elementary school children
7:46 Childhood immunizations
8:13 COVID-19 vaccines
11:41 Emergency Use Authorizations (EUA)
13:37 COVID-19 Long-haulers
15:55 What is happening outside of the US?
18:44 Test, track, trace, and quarantine
20:19 Indoor air circulation
21:58 The CDC
24:42 Outlook for 2021
26:53 Monoclonal antibodies
28:18 Masking, social distancing, outdoor activities
30:01 Face shields vs. masks
31:39 PPE supply chain
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.